Haverford Trust CO Merck & Co., Inc. Transaction History

Haverford Trust CO

$9.55 Billion
Q1 2024

A detailed history of Haverford Trust CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Haverford Trust CO holds 821,450 shares of MRK stock, worth $102 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares

821,450

Previous 814,259 0.88%

Holding current value

$102 Million

Previous $88.8 Million 22.1%

% of portfolio

1.14%

Previous 0.99%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$113.24 - $131.95 $814,308 - $948,852	7,191 Added 0.88%	821,450 $108 Million
Q4 2023 Feb 08, 2024	BUY	$100.18 - $109.02 $587,054 - $638,857	5,860 Added 0.72%	814,259 $88.8 Million
Q3 2023 Nov 09, 2023	SELL	$102.95 - $114.33 $2.73 Million - $3.04 Million	-26,565 Reduced 3.18%	808,399 $83.2 Million
Q2 2023 Aug 08, 2023	SELL	$108.61 - $118.38 $773,085 - $842,628	-7,118 Reduced 0.85%	834,964 $96.3 Million
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $14.3 Million - $15.9 Million	-138,489 Reduced 14.12%	842,082 $89.6 Million

Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $336,731 - $431,735	-3,851 Reduced 0.39%	980,571 $109 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $1.45 Million - $1.63 Million	17,143 Added 1.77%	984,422 $84.8 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $319,516 - $362,187	3,827 Added 0.4%	967,279 $88.2 Million
Q1 2022 May 05, 2022	BUY	$73.51 - $82.4 $4.4 Million - $4.93 Million	59,841 Added 6.62%	963,452 $79.1 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $2.04 Million - $2.56 Million	28,248 Added 3.23%	903,611 $69.3 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $2.09 Million - $2.3 Million	29,146 Added 3.44%	875,363 $65.7 Million
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $54.9 Million - $60.7 Million	780,407 Added 1185.85%	846,217 $65.8 Million
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $51.8 Million - $57.3 Million	-736,888 Reduced 91.8%	65,810 $65.8 Million
Q1 2021 May 12, 2021	BUY	$68.86 - $81.11 $7.93 Million - $9.34 Million	115,181 Added 16.75%	802,698 $61.9 Million
Q4 2020 Feb 05, 2021	BUY	$71.77 - $79.65 $1.5 Million - $1.67 Million	20,933 Added 3.14%	687,517 $56.2 Million
Q3 2020 Nov 10, 2020	BUY	$73.18 - $82.95 $3.68 Million - $4.17 Million	50,242 Added 8.15%	666,584 $55.3 Million
Q2 2020 Aug 13, 2020	BUY	$70.42 - $80.13 $2.96 Million - $3.37 Million	41,999 Added 7.31%	616,342 $47.7 Million
Q1 2020 May 11, 2020	BUY	$63.36 - $87.82 $2.44 Million - $3.38 Million	38,495 Added 7.18%	574,343 $44.2 Million
Q4 2019 Feb 10, 2020	SELL	$77.58 - $87.54 $77,890 - $87,890	-1,004 Reduced 0.19%	535,848 $48.7 Million
Q3 2019 Nov 04, 2019	BUY	$76.08 - $82.93 $612,063 - $667,171	8,045 Added 1.52%	536,852 $45.2 Million
Q2 2019 Aug 13, 2019	BUY	$69.84 - $81.59 $343,822 - $401,667	4,923 Added 0.94%	528,807 $44.3 Million
Q1 2019 May 09, 2019	BUY	$69.58 - $79.36 $658,018 - $750,507	9,457 Added 1.84%	523,884 $43.6 Million
Q4 2018 Feb 12, 2019	SELL	$65.24 - $75.71 $465,487 - $540,190	-7,135 Reduced 1.37%	514,427 $39.3 Million
Q3 2018 Nov 08, 2018	SELL	$57.69 - $67.84 $324,506 - $381,600	-5,625 Reduced 1.07%	521,562 $37 Million
Q2 2018 Aug 10, 2018	SELL	$50.83 - $59.72 $413,705 - $486,061	-8,139 Reduced 1.52%	527,187 $32 Million
Q1 2018 May 09, 2018	SELL	$50.96 - $59.23 $9.24 Million - $10.7 Million	-181,221 Reduced 25.29%	535,326 $29.2 Million
Q4 2017 Feb 13, 2018	BUY	$51.62 - $61.64 $182,838 - $218,328	3,542 Added 0.5%	716,547 $40.3 Million
Q3 2017 Nov 09, 2017	BUY	$58.67 - $63.13 $499,223 - $537,173	8,509 Added 1.21%	713,005 $45.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	704,496	704,496 $45.2 Million

Others Institutions Holding MRK

# of Institutions

3,766

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $314B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Haverford Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Haverford Trust CO with notifications on news.

Account

Haverford Trust CO Merck & Co., Inc. Transaction History